Funded Tech Companies
Exonics Therapeutics
Exonics Therapeutics, based in Cambridge, received equity investments through The Column Group and CureDuchenne Ventures.
Company Overview
Company Name
Exonics Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Bdwy. 14th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Company Background Information
Overview
At Exonics Therapeutics, our mission is to permanently correct genetic mutations resulting in neuromuscular diseases like Duchenne muscular dystrophy. Duchenne is a devastating muscle disease in children, primarily boys, caused by the absence of dystrophin.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/9/2017
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Ripple
Chief Scientific Officer
Eric Olson
Company Investors
- The Column Group (David Goeddel)
- CureDuchenne Ventures (Debra Miller)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs